6505--***EMERGENCY*** 561-24-1-045-0033 | 36C242-24-AP-0146 SHORT TERM CHEMO COMPOUNDING FY24Q1 Sole Source Notice

Closed Special Notice Posted

Solicitation number
36C24224AP0146
Agency
Responses due
Set-aside
No set-aside

Opportunity facts

Notice details come from SAM.gov. Updated .

About this opportunity

This Special Notice was published by the Department of Veterans Affairs to announce their intent to award a sole source contract. The VA East Orange VAMC requires compounded chemotherapy to be delivered ready for administration to veterans with oncology appointments until their permanent or temporary compounding areas are certified.

The Notice aims to procure this compounded chemotherapy from Optum Pharmacy 801, Inc. on a short-term basis through a firm fixed price contract valued at $240,000. Interested parties cannot submit a response as this is not a request for quotes. The compounded drugs must be delivered in final form and ready for administration with tight timelines to continue serving veteran patients. No alternative suppliers were identified who could meet these demands other than the intended awardee. The Notice establishes an October 31, 2023 deadline at 4PM Eastern Time for the contract to be awarded on a non-competitive basis due to the urgent need.

Notice text

This is a notice of intent to award a sole source contract and is not a request for quotes.

The Department of Veterans Affairs East Orange VAMC intends to award a Firm Fixed Price sole source open market action

Name of Contractor:

OPTUM PHARMACY 801, INC.

Street Address:

23620 N 20TH DR STE 12

City, State, Zip:

Phoenix, AZ 85085

The objective of this action is the procurement for:

This is a request for other than full and open competition for the procurement of compounded

chemotherapy delivered in the final form ready for administration to Veterans with oncology appointments at the VA New Jersey Health Care System, East Orange, NJ. We did not identify an alternative source for chemotherapy supplied under such tight timelines when we placed our inquiry with other VA pharmacies. We must be able to continue to provide chemotherapy from an outside source until either our permanent chemotherapy suite or our temporary compounding area has passed certification and viable particle testing.

Files

File Type Posted
P03 - Open Market Single Source Justification MPT to SAT.pdf PDF
36C24224P0077.docx DOCX document

Similar open opportunities

Opportunity Agency Set-aside Responses due
6505--INTENT TO SOLE SOURCE Radiopharm - Lutathera & Pluvicto - Lebanon VAMC NAICS 325412 Veterans Integrated Service Network 4 No set-aside

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity

GovTribe for Federal Contractors